Bloom Energy
BE
$218.50
+7.15%
Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation, with its fuel-flexible Bloom Energy Servers running on natural gas, biogas, or hydrogen to deliver 24/7 stationary electricity to commercial and industrial customers, primarily in the United States but also internationally. The company is the proven, scaled leader in the stationary fuel cell niche — a capital-intensive hardware business now being re-rated as an AI data center power supplier rather than a speculative cleantech developer, a distinction reinforced by its September 2026 addition to the S&P 500. The investor narrative has shifted decisively toward the AI power bottleneck: surging data center electricity demand, a backlog reported at roughly $20 billion (about five times current-year expected revenue), record quarterly results, and a raised outlook are the bull case, while bears point to a stock trading at extreme multiples of forward earnings and sales, execution and manufacturing ramp risk, and a violent post-earnings sell-off despite record revenue. Recent headlines capture the tension precisely — Motley Fool asks whether the October slump is a buying opportunity given record results and a stellar backlog, while simultaneously warning that the rich valuation and execution risk warrant caution.…
BE
Bloom Energy
$218.50
Related headlines
Investment Opinion: Should I buy BE Today?
Rating: Hold with a constructive bias. The core thesis is that Bloom has transformed from a speculative cleantech developer into a profitable AI power supplier — Q2 2026 revenue of $1.065 billion (+165.5% YoY), net income of $196.3 million, and TTM free cash flow of $628.2 million — but the current 36.94x forward PE already discounts much of that success. The analyst consensus is Buy (mean 2.24) with an average target of $285.08, implying +47.5% upside, which anchors a favorable medium-term view even as near-term momentum is negative.
Supporting evidence is strong on growth and cash but stretched on valuation: revenue grew 165.5% YoY with gross margin at 33.4% and operating margin at 17.1%; TTM FCF of $628.2 million is self-funding against Q2 capex of just $51.6 million; and the ~$20 billion backlog is about 5x current-year revenue. However, PS of 10.32x and EV/Sales of 20.64x are roughly 2–4x the electrical equipment sector norm, price-to-book of 27.2x is far above the low-to-mid single-digit sector norm, and the 36.94x forward PE is about double the sector's high-teens multiple. The implied +47.5% upside to the average target is real but comes with a target range of $97–$380, signaling very low conviction.
The biggest risks that could invalidate the thesis are backlog conversion slippage, gross margin compression below 30%, and a de-rating toward sector multiples. This Hold would upgrade to Buy if the stock reclaims the $240–$250 resistance zone while gross margin holds above 33%, or if forward PE compresses below 30x on sustained earnings delivery; it would downgrade to Sell if revenue growth decelerates below 50% or if the stock breaks decisively below the $163–$167 support. Valuation verdict: fairly valued to modestly overvalued relative to history and peers — the premium is justified by growth but leaves little room for error.
Sign up to view all
BE 12-Month Price Forecast
Bloom's fundamental trajectory is genuinely impressive — 165.5% revenue growth, an 18.4% net margin, and $628.2 million in TTM free cash flow — and the ~$20 billion backlog provides multi-year visibility. However, the 36.94x forward PE, 10.32x PS, and 27.2x price-to-book already price in near-flawless execution, and the stock's -29.76% one-month decline shows the market is actively testing that assumption. The analyst consensus Buy with a $285.08 average target supports a constructive medium-term view, but the $97–$380 range and 3.776 beta argue for disciplined position sizing rather than aggressive accumulation. I would upgrade to bullish if the stock reclaims $240–$250 with gross margin above 33%, and downgrade to bearish if it breaks below $163–$167 or if backlog conversion visibly slows.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bloom Energy's 12-month outlook, with a consensus price target around $284.77 and implied upside of +30.3% versus the current price.
Average Target
$284.77
0 analysts
Implied Upside
+30.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$102 - $380
Analyst target range
Coverage is broad with 26 analysts, and the consensus recommendation is Buy (mean rating of 2.24 on a scale where 1 is Strong Buy and 5 is Strong Sell), with an average target price of $285.08 — implying +47.5% upside from the current $193.30. The consensus leans bullish, and the average target sits well above the current price despite the recent 29.8% one-month decline, indicating that analysts have not yet capitulated to the sell-off; the estimated average EPS of $12.94 (range $9.72–$16.83) and average revenue of $15.55 billion (range $12.57–$19.14 billion) show the Street expects a massive step-up from current run-rate levels. The target range is extremely wide — from a low of $97.00 to a high of $380.00, a spread of nearly 4x — which signals very high uncertainty and low conviction in the terminal value of the growth story. The high target of $380 assumes flawless backlog conversion, sustained margin expansion toward the mid-30s gross margin, and multiple expansion as the AI data center narrative matures; the low target of $97 prices in margin compression, manufacturing execution failures, competitive losses to alternatives like gas turbines or grid solutions, and a de-rating toward industrial-sector multiples. Institutional ratings show a mixed but stabilizing pattern: recent actions include Jefferies reiterating Hold (Sept 29), RBC Capital and Mizuho reiterating Outperform (Sept 28 and Sept 14), Bernstein maintaining Market Perform (Aug 27), and Mizuho upgrading from Neutral to Outperform on July 30 — a net positive drift, but the persistence of Hold/Equal Weight ratings from Jefferies, Wells Fargo, and Truist alongside Buy ratings from UBS and BTIG reflects genuine two-sided debate about valuation versus execution.
Bulls vs Bears: BE Investment Factors
The bull case currently rests on stronger fundamental evidence: 165.5% revenue growth, a genuine profitability inflection to an 18.4% net margin, $628.2 million in TTM free cash flow, and a ~$20 billion backlog that is roughly 5x current-year revenue. The bear case is primarily about price and timing rather than business quality — a 36.94x forward PE, 10.32x PS, and 27.2x price-to-book embed near-flawless execution, and the stock's -29.76% one-month decline with a -52.65% max drawdown shows the market is already repricing that risk. The single most important tension is backlog conversion: whether Bloom can turn its ~$20 billion pipeline into revenue at 30%+ gross margins without slippage will determine whether the multiple holds or compresses toward sector norms. On balance, the fundamental evidence is stronger than the price action, but the valuation and momentum argue for patience rather than aggressive accumulation at current levels.
Bullish
- Revenue inflecting at hyper-growth pace: Q2 2026 revenue hit $1.065 billion, up 165.5% YoY from $401.2 million and 41.8% sequentially from Q1's $751.1 million. The multi-quarter trajectory ($519M → $778M → $751M → $1,065M) shows acceleration consistent with the ~$20 billion backlog, roughly 5x current-year expected revenue.
- Profitability inflection is real and rapid: Q2 2026 net income of $196.3 million (18.4% net margin) versus a -$42.6 million loss a year earlier, with operating margin at 17.1% and EBITDA of $223.0 million (20.9% margin). Four consecutive profitable quarters (Q4 2025 through Q2 2026) mark a genuine turn from the loss-making 2025 quarters.
- Strong balance sheet and self-funding cash flow: Cash of $2.69 billion against a current ratio of 5.98, Q2 operating cash flow of $226.5 million, free cash flow of $174.8 million, and TTM FCF of $628.2 million. Capex of only $51.6 million in Q2 means growth is now funded internally rather than through external capital.
- Analyst consensus still bullish with big upside: 26 analysts carry a Buy consensus (mean rating 2.24) with an average target of $285.08, implying +47.5% upside from $193.30. The high target of $380 and average EPS estimate of $12.94 show the Street expects a massive earnings step-up, and analysts have not capitulated despite the 29.8% one-month decline.
Bearish
- Extreme valuation leaves no margin for error: Forward PE of 36.94x on consensus 2027 EPS of $12.94, PS of 10.32x, EV/Sales of 20.64x, and price-to-book of 27.2x represent roughly 2–4x the electrical equipment sector norm. The market is pricing near-flawless execution, and the 183x price-to-cash-flow ratio shows how much sustained cash generation is embedded in the equity.
- Violent correction and bearish momentum divergence: The stock is down 29.76% over the past month versus SPY's -1.02% (relative strength -28.74%), and fell 11.24% in the latest session alone on 35.9 million shares. With a max drawdown of -52.65% from peak and a 6-month change of -16.38% versus SPY's +6.45%, the parabolic advance has broken into a lower-highs, lower-lows structure.
- Backlog conversion is slow and lumpy: Only about $6 billion of the ~$20 billion backlog converts as product revenue over 1–2 years, meaning the headline backlog overstates near-term revenue. Large product orders make sequential growth non-linear, and any conversion delay or margin slippage would directly challenge the growth premium.
- Leverage and recent unprofitability: Debt-to-equity of 3.89 and total debt to capitalization of 63.6% reflect meaningful leverage, while the trailing-twelve-month net margin of -4.37% and ROE of -11.5% show how recently the turn occurred. A working-capital-driven cash burn like the -$220.4 million FCF quarter in Q2 2025 remains a live risk.
BE Technical Analysis
Bloom Energy is in a powerful but extraordinarily volatile primary uptrend: the stock is up 90.59% over the past year and 95.87% year-to-date, massively outperforming the S&P 500's 13.13% and 11.45% respective gains, with relative strength of +77.46% over one year and +84.42% YTD. At $193.30, the stock sits at roughly 42.8% of its 52-week range of $75.70 to $351.28 — closer to the low than the high despite the huge annual gain, meaning the entire advance was front-loaded and the stock has been unwinding from its highs. That positioning is neither a clean momentum breakout nor a deep-value falling knife, but rather a high-beta name in a violent correction phase, with a maximum drawdown of -52.65% from peak confirming the severity of the retracement. Recent momentum has deteriorated sharply and is diverging bearishly from the longer-term trend: the stock is down 29.76% over the past month versus a -1.02% decline in SPY (relative strength of -28.74%), and the most recent session alone saw an -11.24% drop from $217.77 to $193.30 on heavy volume of 35.9 million shares. The 3-month change of +4.55% (versus SPY +2.85%) shows the stock was still holding up through mid-summer, but the 6-month change of -16.38% versus SPY's +6.45% (relative strength -22.83%) reveals a persistent loss of leadership since the spring peak — a classic pattern of a parabolic mover entering a lower-highs, lower-lows corrective structure. Key levels are well defined: support sits at the 52-week low of $75.70, with intermediate support near the July/August trough around $163.75–$166.84, while resistance is anchored at the 52-week high of $351.28 and the recent $295–$307 supply zone. A decisive break below the $163–$167 area would confirm a deeper trend reversal and likely target the $120s, whereas reclaiming $240–$250 would signal the correction has bottomed; with a beta of 3.776 — nearly four times the market's volatility — position sizing must account for daily swings that can exceed 10%, as the latest session demonstrated.
Beta
3.78
3.78x market volatility
Max Drawdown
-52.6%
Largest decline past year
52-Week Range
$76-$351
Price range past year
Annual Return
+101.3%
Cumulative gain past year
| Period | BE Return | S&P 500 |
|---|---|---|
| 1m | -24.3% | -0.2% |
| 3m | +33.4% | +5.5% |
| 6m | -22.9% | +7.1% |
| 1y | +101.3% | +12.3% |
| ytd | +121.4% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BE Fundamental Analysis
Revenue is inflecting dramatically: Q2 2026 revenue reached $1.065 billion, up 165.5% year-over-year versus $401.2 million in Q2 2025, and up 41.8% sequentially from Q1 2026's $751.1 million, which itself was up 130% from Q1 2025's $326.0 million. The multi-quarter trajectory shows clear acceleration — quarterly revenue climbed from $519.0 million in Q3 2025 to $777.7 million in Q4 2025, $751.1 million in Q1 2026, and $1.065 billion in Q2 2026 — with the Product segment ($935.4 million) overwhelmingly driving the business, dwarfing Service ($69.0 million), Installation ($52.8 million), and Electricity ($10.0 million). This growth is consistent with the data center power narrative and the reported ~$20 billion backlog, but the lumpiness of large product orders means sequential growth will not be linear, and the investment case now hinges on converting backlog into revenue without margin slippage. Profitability has turned decisively positive: Q2 2026 net income was $196.3 million (18.4% net margin) versus a -$42.6 million loss in Q2 2025, with gross margin at 33.4% (up from 36.1% a year earlier but improving from 30.0% in Q1 2026 and 30.8% in Q4 2025), operating margin at 17.1%, and EBITDA of $223.0 million (20.9% margin) versus -$14.1 million a year ago. The company has strung together four consecutive profitable quarters (Q4 2025 net income of $1.1 million, Q1 2026 $70.7 million, Q2 2026 $196.3 million), a genuine inflection from the loss-making 2025 quarters, though the trailing-twelve-month net margin of -4.37% and ROE of -11.5% show how recently the turn occurred and how much of the year was still unprofitable. Balance sheet and cash generation are strong: cash at the end of Q2 2026 was $2.69 billion against a current ratio of 5.98, Q2 operating cash flow was $226.5 million with free cash flow of $174.8 million and TTM FCF of $628.2 million, and the debt-to-equity ratio of 3.89 reflects a capital structure still carrying meaningful leverage (total debt to capitalization of 63.6% as of Q2). The company is now self-funding growth internally — Q2 capex was only $51.6 million against $226.5 million of operating cash flow — but the 3.89x debt-to-equity and 183x price-to-cash-flow ratio mean the equity is priced for sustained cash generation, leaving little room for a working-capital-driven cash burn like the -$220.4 million FCF quarter seen in Q2 2025.
Quarterly Revenue
$1.1B
2026-06
Revenue YoY Growth
+165.5%
YoY Comparison
Gross Margin
33.4%
Latest Quarter
Free Cash Flow
$628164000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BE Overvalued?
Because trailing net income is negative (EPS of -$0.0042, trailing PE of -234.8x), the PE ratio is not a valid primary metric; the appropriate lead metric is the forward PE, which at 36.94x on consensus 2027 EPS of $12.94 reflects the market pricing in the profitability inflection, while the PS ratio of 10.32x and EV/Sales of 20.64x frame the revenue-based valuation. The gap between the negative trailing PE and the 36.94x forward PE is enormous and implies the market expects earnings to inflect from roughly breakeven to nearly $13 per share within a year — an aggressive assumption that leaves the stock highly sensitive to any guidance miss. The EV/EBITDA of 1,068.6x is distorted by the still-small TTM EBITDA base and is not analytically useful at this stage. On a peer basis, the PS ratio of 10.32x and EV/Sales of 20.64x represent a steep premium to the electrical equipment and industrial sector, where mid-single-digit sales multiples are typical — a premium of roughly 2–4x the sector norm — and the 27.2x price-to-book ratio versus a sector norm in the low-to-mid single digits underscores how much future growth and margin expansion is embedded in the price. The premium is partially justified by 165% revenue growth and a ~$20 billion backlog, but the PEG ratio of -1.27 (negative because of trailing losses) and the 36.94x forward PE versus a sector forward multiple in the high teens imply the market is paying roughly double the sector for growth that must persist for years to validate the multiple. Historically, Bloom's own valuation band has been extreme and volatile: PS ranged from 7.3x in Q3 2024 to 81.6x in Q2 2026 (the latter inflated by a much smaller share count and lower revenue base), and the current 10.32x PS sits well below the Q2 2026 peak of 81.6x but above the 2024 trough of ~7.3x — suggesting the stock is in the middle-to-upper portion of its historical range rather than at a bargain. The forward PE of 36.94x compares with a Q2 2026 trailing PE of 111.3x and a Q1 2026 PE of 135.5x, showing rapid multiple compression as earnings catch up — a healthy sign if it continues, but the market is still pricing in optimistic, near-flawless execution.
PE
-234.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~184x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
1068.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on leverage and the recency of profitability. Debt-to-equity of 3.89 and total debt to capitalization of 63.6% mean the capital structure still carries meaningful leverage even as cash sits at $2.69 billion with a 5.98 current ratio. The trailing-twelve-month net margin of -4.37% and ROE of -11.5% show that most of the past year was unprofitable, so the four-quarter profit streak is young and vulnerable to a single weak quarter. Revenue is also highly concentrated in the Product segment ($935.4 million of $1.065 billion in Q2), making results hostage to the timing and margin of large orders; a working-capital swing like the -$220.4 million FCF quarter in Q2 2025 could recur and pressure the 183x price-to-cash-flow valuation.
Market and competitive risks are dominated by valuation compression and volatility. At 36.94x forward PE, 10.32x PS, and 20.64x EV/Sales, Bloom trades at roughly 2–4x the electrical equipment sector's mid-single-digit sales multiples, leaving little cushion if growth decelerates or margins slip. Beta of 3.776 makes the stock nearly four times as volatile as the market, and the -29.76% one-month decline versus SPY's -1.02% illustrates how quickly sentiment can reverse. Competition from gas turbines, grid solutions, and rival fuel-cell makers like FuelCell Energy and Plug Power could cap pricing, while the AI data center narrative that drives demand is itself sensitive to a slowdown in hyperscaler capex.
Worst-case scenario: backlog conversion slips, gross margin compresses from the current 33.4% toward the low-20s, and the market de-rates the stock toward industrial-sector multiples. That chain would likely take the shares back toward the July/August trough of $163.75–$166.84 first, and a decisive break there would target the $120s, with the 52-week low of $75.70 and the analyst low target of $97 as the extreme downside anchors. From $193.30, a move to the $97 analyst low represents roughly -50%, and a retest of the $75.70 52-week low would be about -61% — consistent with the stock's demonstrated -52.65% max drawdown.
FAQ
The most severe risk is valuation compression: at 36.94x forward PE and 10.32x PS, roughly 2–4x sector norms, any growth deceleration would trigger a sharp de-rating. Second is execution and backlog conversion risk — only about $6 billion of the ~$20 billion backlog converts over 1–2 years, and large product orders make revenue lumpy, with gross margin already down from 36.1% a year ago to 33.4%. Third is financial leverage and cash-flow volatility, with debt-to-equity of 3.89 and a prior -$220.4 million FCF quarter showing working-capital risk. Fourth is extreme market volatility, with beta of 3.776 and a -52.65% max drawdown meaning a single guidance miss can wipe out a third of the position, as the -29.76% one-month decline versus SPY's -1.02% demonstrated.
The 12-month forecast has three scenarios: a base case (50% probability) targeting $250–$290, aligned with the analyst average of $285.08, assuming steady backlog conversion and gross margin in the low-to-mid 30s; a bull case (25%) targeting $340–$380, aligned with the analyst high of $380 and the 52-week high of $351.28, requiring margin expansion toward the mid-30s and multiple expansion; and a bear case (25%) targeting $97–$165, aligned with the analyst low of $97 and the July/August trough of $163.75–$166.84, driven by backlog slippage and margin compression. The base case is most likely, with the key assumption being that revenue tracks toward the $15.55 billion consensus and forward PE compresses modestly as EPS approaches $12.94.
BE appears fairly valued to modestly overvalued. The trailing PE of -234.8x is not meaningful given negative trailing EPS, so the forward PE of 36.94x on consensus 2027 EPS of $12.94 is the key metric — roughly double the electrical equipment sector's high-teens forward multiple. PS of 10.32x and EV/Sales of 20.64x are about 2–4x the sector norm, and price-to-book of 27.2x dwarfs the low-to-mid single-digit sector average. Against its own history, the 10.32x PS sits well below the Q2 2026 peak of 81.6x but above the 2024 trough of ~7.3x, placing it in the middle-to-upper portion of its range. The market is paying a premium that implies sustained 30%+ growth and margin expansion for years; if that delivery falters, multiple compression toward sector norms would be severe.
From a risk/reward perspective, BE offers meaningful upside but with substantial downside risk. The analyst average target of $285.08 implies +47.5% upside from $193.30, and the business has genuinely inflected — 165.5% revenue growth, an 18.4% net margin, and $628.2 million in TTM free cash flow. However, the 36.94x forward PE and 10.32x PS leave little room for error, and the stock's -52.65% max drawdown and 3.776 beta show how violently it can reprice. The biggest downside risk is a backlog conversion miss that could take shares toward the $97 analyst low, roughly -50%. It is a good buy for high-risk-tolerant investors with a multi-year horizon who can stomach 10%+ daily swings, ideally accumulated on weakness near the $163–$167 support rather than at current levels.
BE is better suited to long-term holding than short-term trading, but only for investors who can tolerate extreme volatility. The growth stage is early-commercial-scale with a ~$20 billion backlog providing multi-year visibility, and the profitability inflection (four consecutive profitable quarters) supports a multi-year compounding thesis. However, beta of 3.776 and a -52.65% max drawdown make short-term trading hazardous, and the absence of a meaningful dividend (yield of 0.0045%) means there is no income cushion. Earnings visibility is improving but still lumpy given product-order concentration. A suggested minimum holding period is 2–3 years to allow backlog conversion and margin expansion to play out, with position sizing that accounts for 10%+ daily swings and staged entry near the $163–$167 support.